Venture NAV Tracker / Private company
NorthSea Therapeutics
Headquarters—
Founded—
Last known round—
Reported valuation—
Cross-fund comparison
Equity & warrant marks
One latest disclosed mark per fund.
| Fund | Fair value | Security / basis | Implied price / share | Mark age vs round | Methodology / filing |
|---|---|---|---|---|---|
| HTGCHercules Capital, Inc. | $1.3MMar 31, 2026 · source ↗ | equityFair Value | $1,281.79Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | 10-Q 2026-03-31 ↗ |
Cross-fund comparison
Debt investments
One latest disclosed debt mark per fund.
| Fund | Security type / basis | Principal | Fair value | FV / principal | Rate | Maturity | Mark age vs round | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| HTGCHercules Capital, Inc. | senior secured loanFair Value — Convertible Debt | $373KMar 31, 2026 · source ↗ | $373KMar 31, 2026 · source ↗ | 100.0%Mar 31, 2026 · source ↗ | FIXED 6.00 %Mar 31, 2026 · source ↗ | Dec 1, 2026Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.